跳至主要内容
临床试验/CTRI/2022/12/048558
CTRI/2022/12/048558尚未招募3 期

Quantitative assessment of cysticercosis on whole body MRI in patients with disseminated cysticercosis treated with albendazole with steroids vs steroids alone and outcome assessment at 3 months a randomized controlled trial

KING GEORGE MEDICAL UNIVERSITY,UTTAR PRADESH LUCKNOW0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All the cases of disseminated cysticercosis
  • Disseminated cysticercosis will be diagnosed as >= 3 NCC with involvement of at least one extra site like subcutaneous tissues, skeletal muscles, eyes, or presence in any visceral organ.
  • Patients of neurocysticercosis will be diagnosed on the basis of Del Brutto criteria.

排除标准

  • 1)Patient in cysticercal encephalitis.
  • 2)Patient with subretinal cysticercosis.
  • 3)Patients having evidence of systemic illness as malignancy, Tuberculosis, HIV etc
  • 4)Patients with hypersensitivity to albendazole
  • 5)Patients with alcohol /substance abuse
  • 6)Patients with primary psychiatric disease prior to developing neurocysticercosis
  • 7)Pregnant females
  • 8)Patients/ attendants refusing consent

研究者

发起方
KING GEORGE MEDICAL UNIVERSITY,UTTAR PRADESH LUCKNOW

相似试验